Navigation Links
BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
Date:7/28/2008

ill utilize the new, more concentrated 150 mg/ml formulation and needle length guidelines established in recently conducted pharmacokinetic studies.

About BioCryst

BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The Company is advancing multiple internal programs toward potential commercialization including forodesine HCl in oncology, BCX-4208 in psoriasis and peramivir in seasonal and life-threatening influenza. BioCryst is collaborating with Mundipharma for the development and commercialization of forodesine HCl in markets across Europe, Asia, Australia and certain neighboring countries. In January 2007, the U.S. Department of Health and Human Services (HHS) awarded a $102.6 million, four-year contract to BioCryst to advance development of peramivir to treat seasonal and life-threatening influenza. In February 2007, BioCryst established a partnership with Shionogi & Co. to develop and commercialize peramivir in Asia. For more information about BioCryst, please visit the Company's web site at http://www.biocryst.com.

Forward-looking statements

This press release contains forward-looking statements, including statements regarding future results, performance or achievements. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factor
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
2. BioCryst Updates Peramivir Clinical Development Plan
3. BioCryst Provides Forodesine HCl Update
4. BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
5. Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
6. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
7. Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials
8. GeoVax Reports Progress on Its AIDS Vaccine Technology
9. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
10. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
11. Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014   Stone ... settlement of off-label marketing and fraud claims between ... Vascular Solutions, Inc. ("VSI").  The settlement covers fraud ... devices for endovenous laser ablation of varicose veins ... a firm with a history of representing whistleblowers ...
(Date:7/28/2014)... , July 28, 2014  Some 2,500 scientists ... month in Montreal for the ... -- a discipline that draws researchers from fields as ... problems as diverse as designing new manufacturing processes to ... a special time because the United Nations has declared ...
(Date:7/28/2014)... , July 28, 2014  Serco Inc., ... announced the Company has been awarded a re-compete ... Command (NEMSCOM) and its Deployable Medical Systems.  Serco ... medical personnel to provide world-class healthcare to meet ... environment across the globe. The five year contract ...
Breaking Medicine Technology:Stone & Magnanini LLP Announces $520,000 Department of Justice False Claims Act Settlement With Vascular Solutions, Inc. 2Stone & Magnanini LLP Announces $520,000 Department of Justice False Claims Act Settlement With Vascular Solutions, Inc. 3All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 2All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 3All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 4All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 5All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 6Serco Awarded $22.7 Million Contract to Support Deployable Medical Systems 2
... , FRANKLIN LAKES, N.J., Dec. 29 America,s seniors are being ... basis. According to a new national survey of more than 1,000 ... percent) take at least five different prescription drugs regularly and one in ... The challenge of managing multiple medications is clear - nearly three in ...
... , , , , PORTSMOUTH, ... begin giving away over $6,000,000 worth of its new LifeGuard30(TM) ... that cannot afford to buy them as well as to charitable ... mini-computer that stores and displays vital patient information at the scene ...
Cached Medicine Technology:New Survey Shows Seniors Struggle Under the Weight of Multiple Medication Use 2New Survey Shows Seniors Struggle Under the Weight of Multiple Medication Use 3New Survey Shows Seniors Struggle Under the Weight of Multiple Medication Use 4ViVre Medical Announces $6,000,000 Gift 2ViVre Medical Announces $6,000,000 Gift 3
(Date:7/29/2014)... Roanoke, Virginia (PRWEB) July 29, 2014 ... a featured lecturer at the Florida Chiropractic Association (FCA) ... and Their Effects on the Kinetic Chain Changes on ... Florida. Greenawalt’s talk is focusing on the positive impact ... on conditions such as low back pain, plantar fasciitis, ...
(Date:7/29/2014)... 29, 2014 Healthcare staffing agency ... Nurses of Tomorrow Scholarship Competition winners:, ... NV ,     Racheal D., Freshman, Cerritos College ... Houston Community College in Houston, TX ... Medical Solutions hosts the Nurses of Tomorrow Scholarship ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 PharmaSphere: ... Biosimilars Market report is an essential source of ... Using detailed company data, financial analysis, corporate strategy, ... of the current and future growth drivers of ... regulatory frameworks under which biosimilars are currently reviewed ...
(Date:7/29/2014)... 29, 2014 1WorldSync announces B. ... healthcare suppliers will utilize the Global Data Synchronization ... network to share product information with the U.S. ... partners across their global supply chain. Holger Clobes, ... B. Braun: "B. Braun serves customers in 61 ...
(Date:7/29/2014)... Catalent Pharma Solutions, the global leader ... for pharmaceutical, biologic, and consumer health products, today ... US Platform Leader of Pharmaceutical Softgels, will present ... Formulations using Soft Capsule Delivery Systems” at the ... of Drug Delivery Systems (30-31 July 2014, Tokyo, ...
Breaking Medicine News(10 mins):Health News:Foot Levelers CEO Kent Greenawalt Speaking at FCA Convention 2Health News:Medical Solutions Announces Nurses of Tomorrow Scholarship Winners 2Health News:World Biosimilars Market Value Exceed $262 Billion by 2019 Says a New Report Available at MarketOptimizer.org 2Health News:World Biosimilars Market Value Exceed $262 Billion by 2019 Says a New Report Available at MarketOptimizer.org 3Health News:World Biosimilars Market Value Exceed $262 Billion by 2019 Says a New Report Available at MarketOptimizer.org 4Health News:B. Braun Selects 1WorldSync Unique Device Identification and Product Information Solution 2Health News:B. Braun Selects 1WorldSync Unique Device Identification and Product Information Solution 3Health News:Catalent Expert to Present on Enhancing Bioavailability of Poorly Absorbed Drugs at Japan Society of Drug Delivery Systems 2
... pre-packed Camembert to shrink-wrapped meat loaf choosing the ... industry. Companies need to protect food products from oxygen, ... fresh for as long as possible. Transparent multilayer films, ... used to protect food from contamination. To minimize the ...
... Tuning in to tune out may be just what,s ... at the Duke Cancer Institute. The Duke team found ... pain and anxiety of the often uncomfortable procedure. The ... points to a simple and inexpensive way to help an ...
... This release is available in Spanish . ... gather and characterise in detail 110 cases of cardiac rupture ... Hospital de Cruces, near Bilbao. It is one of the ... most serious complication of acute myocardial infarction; it is not ...
... new study by NYU Langone Medical Center researchers identified ... of fat and cholesterol that hardens into plaque and ... Immunology on January 8, 2012, explains why cholesterol-laden, ... plaques. "We have discovered that macrophages that accumulate ...
... , SUNDAY, Jan. 8 (HealthDay News) -- People ... genes as those in the general population, but they may ... so long, researchers report. The team of U.S. scientists ... with only one per 5 million people in developed nations. ...
... at the Translational Genomics Research Institute (TGen) have begun ... to lung cancer in never-smokers a first step ... starting point. We certainly have a lot of pathways ... very interested in confirming and looking at in larger ...
Cached Medicine News:Health News:Film coatings made from whey 2Health News:Film coatings made from whey 3Health News:Headphone music eases anxiety during prostate biopsies 2Health News:Keys for detecting cardiac rupture 2Health News:Keys for detecting cardiac rupture 3Health News:Researchers discover new culprit in atherosclerosis 2Health News:Why Some People Live to 110 2Health News:TGen researchers map potential genetic origins, pathways of lung cancer in nonsmokers 2
... is an excellent choice to treat DeQuervain's ... joint, basal joint arthritis, advanced carpal tunnel ... thumb and wrist. Distal palmar crease ... and full finger dexterity. Constructed from ...
... Wrist Flex is a custom wrist orthotic designed to ... to the patient's maximum range-of-motion. , ,Indications: , ... TFCC tear-triangular fibrocartilage complex , Coles fracture ... , Partial tendon rupture , ORIF ...
The Contoured Wrist/Forearm Support provides comfort for post-surgical immobilization, post-fracture casting, and wrist sprains and strains....
Design allows for easy-one hand application to provide support and immobilization of the wrist while preserving finger mobility...
Medicine Products: